{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:48:52Z","timestamp":1761058132247},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf00449687","type":"journal-article","created":{"date-parts":[[2004,11,13]],"date-time":"2004-11-13T03:20:23Z","timestamp":1100316023000},"page":"30-34","source":"Crossref","is-referenced-by-count":10,"title":["Safety of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in patients with human immunodeficiency virus infection"],"prefix":"10.1007","volume":"18","author":[{"given":"S.","family":"Arends","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Halteren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schokker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","volume":"317","author":"M Fischl","year":"1987","unstructured":"Fischl M, Richman D, Grieco M, Gottlieb M, Volberding P, Laskin O, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:185?91.","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJM199005103221902","volume":"322","author":"JS Lambert","year":"1990","unstructured":"Lambert JS, Seidlin M, Reichman R, Plank C, Laverty M, Morse G, et al. 2?,3?-Dideoxyinosine (ddl) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N Engl J Med 1990;322:1340?5.","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-119-8-199310150-00003","volume":"119","author":"A Collier","year":"1993","unstructured":"Collier A, Coombs R, Fischl M, Skolnik P, Northfelt D, Boutin P, et al. Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med 1993;119:786?93.","journal-title":"Ann Intern Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-116-1-13","volume":"116","author":"T Meng","year":"1992","unstructured":"Meng T, Fischl M, Boota A, Spector SA, Bennett D, Bassiakos Y, et al. Combination therapy with zidovudine and dide-oxycytidine in patients with advanced human immuno-deficiency virus infection: a phase I\/II study. Ann Intern Med 1992;116:13?20.","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJM198707233170402","volume":"317","author":"D Richman","year":"1987","unstructured":"Richman D, Fisch M, Grieco M, Gottlieb M, Volberding P, Loskin O, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:192?7.","journal-title":"N Engl J Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","volume":"323","author":"E Clercq De","year":"1986","unstructured":"De Clercq E, Hol\u00fd A, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC. A novel selective broad-spectrum anti-DNA virus agent. Nature 1986;323:464?7.","journal-title":"Nature"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-291X(91)91818-W","volume":"178","author":"J Balzarini","year":"1991","unstructured":"Balzarini J, Perno C-F, Schols D, de Clercq E. Activity of acyclic nucleoside phosphonates analogues against human immunodeficiency virus in monocyte\/macrophages and peripheral blood lymphocytes. Biochem Biophys Res Commun 1991;178:329?35.","journal-title":"Biochem Biophys Res Commun"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/AAC.32.7.1025","volume":"32","author":"R Pauwels","year":"1988","unstructured":"Pauwels R, Balzarini J, Schols D, Baba M, Desmyter J, Rosenberg I, et al. Phosphonylmethoxyethyl purine derivatives a new class of anti-human immunodeficiency virus agents. Antimicrob Agents Chemother 1988;32:1025?30.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1073\/pnas.86.1.332","volume":"86","author":"J Balzarini","year":"1989","unstructured":"Balzarini J, Naesens L, Herdewijn P, Rosenberg I, Hol\u00fd A, Pauwels R, et al. Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. Proc Natl Acad Sci USA 1989;86:332?6.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"Heijtink R, de Wilde G, Kruining J, Berk L, Balzarini J, De Clercq E, et al. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infection. Antiviral Res 21:141?53.","DOI":"10.1016\/0166-3542(93)90050-S"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/AAC.38.9.2180","volume":"38","author":"R Heijtink","year":"1994","unstructured":"Heijtink R, Kruining J, de Wilde G, Balzarini J, de Clercq E, Schalm S. Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture. Antimicrob Agents Chemother 1994;38:2180?2.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/AAC.35.2.394","volume":"35","author":"T Yokota","year":"1991","unstructured":"Yokota T, Mochizuki S, Konno K, Mori S, Shigeta S, de Clercq E. Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis. Antimicrob Agents Chemother 1991;35:394?7.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR13","first-page":"537","volume":"42","author":"J Cerny","year":"1991","unstructured":"Cerny J, Foster S, Cheng Y. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells. Mol Pharmacol 1991;42:537?44.","journal-title":"Mol Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/AAC.33.2.185","volume":"33","author":"E Clercq De","year":"1989","unstructured":"De Clercq E, Hol\u00fd A, Rosenberg I. Efficacy of phosphonyl-methoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo. Antimicrob Agents Chemother 1989;33:185?91.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1128\/AAC.33.11.1864","volume":"33","author":"J Gangemi","year":"1989","unstructured":"Gangemi J, Cozens RM, de Clercq E, Balzarini J, Hochkeppel H. 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections. Antimicrob Agents Chemother 1989;33:1864?8.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0166-3542(90)90049-D","volume":"14","author":"V Vonka","year":"1990","unstructured":"Vonka V, Anisimova E, Cerny J, Hol\u00fd A, Rosenberg I, Votruba I. Properties of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) resistant herpes simplex type 1 virus. Antiviral Res 1990;14:117?21.","journal-title":"Antiviral Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/AAC.31.9.1431","volume":"31","author":"J Lin","year":"1987","unstructured":"Lin J, de Clercq E, Pagano JS. Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication. Antimicrob Agents Chemother 1987;31:1431?3.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0166-3542(91)90062-V","volume":"16","author":"L Castro De","year":"1991","unstructured":"De Castro L, Kern E, de Clercq E, Ghaffar A, Mayer E, Vogt P, et al. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS. Antiviral Res 1991;16:101?14.","journal-title":"Antiviral Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00002030-199101000-00003","volume":"5","author":"J Balzarini","year":"1991","unstructured":"Balzarini J, Naesens L, Slachmuylders J, Niphuis H, Rosenberg I, Hol\u00fd A, et al. 9-(2-Phosphonomethoxyethyl)adenine (PMEA) effectively inhibits retrovirus replication in vitro and simian immunodeficiency virus infection in rhesus monkeys. AIDS 1991;5:21?8.","journal-title":"AIDS"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1073\/pnas.87.8.3087","volume":"87","author":"H Egberink","year":"1990","unstructured":"Egberink H, Borst M, Niphuis H, Balzarini J, Neu H, Schellekens H, et al. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci USA 1990;87:3087?91.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-2427(92)90129-E","volume":"35","author":"K Hartmann","year":"1992","unstructured":"Hartmann K, Donath A, Beer B, Egberink H, Horzenik M, Lutz H, et al. Use of two virustacia (AZT, PMEA) in treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol 1992;35:167?75.","journal-title":"Vet Immunol Immunopathol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0684.1994.tb00119.x","volume":"23","author":"C Tsai","year":"1994","unstructured":"Tsai C, Follis K, Grant R, Sabo A, Nolte R, Bartz C, et al. Comparison of the efficacy of AZT and PMEA treatment against acute SIVmne infection in macaques. J Med Primatol 1994;23:175?83.","journal-title":"J Med Primatol"},{"key":"CR23","first-page":"111","volume":"37","author":"A Merta","year":"1990","unstructured":"Merta A, Vesely I, Votruba I, Rosenberg I, Hol\u00fd A. Phosphorylation of acyclic nucleotide analogues HPMPA and PMEA in L210 mouse leukemic cell extracts. Neoplasma 1990;37:111?20.","journal-title":"Neoplasma"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1073\/pnas.88.4.1499","volume":"88","author":"J Balzarini","year":"1991","unstructured":"Balzarini J, Hao Z, Herdewijn P, Johns DG, de Clercq E. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxy)ethyladenine, a potent anti-human immunodeficiency virus compound. Proc Natl Acad Sci USA 1991;88:1499?503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/clinchem\/38.4.480","volume":"38","author":"L Naessens","year":"1992","unstructured":"Naessens L, Balzarini J, de Clercq E. Acyclic adenine nucleoside phosphonates in plasma determined by high-performance liquid with fluorescence detection. Clin Chem 1992;38:480?5.","journal-title":"Clin Chem"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0378-4347(91)80498-2","volume":"572","author":"JW Russell","year":"1991","unstructured":"Russell JW, Marrero D, Whiterock VJ, Klunk LJ, Starrett JE. Determination of 9-(2-phosphonylmethoxy)ethyladenine in rat urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1991;572:321?6.","journal-title":"J Chromatogr"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0166-3542(91)90059-Z","volume":"16","author":"V Gobbo Del","year":"1991","unstructured":"Del Gobbo V, Foli A, Balzarini J, de Clercq E, Balestra E, Viliani N, et al. Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models. Antiviral Res 1991;16:65?75.","journal-title":"Antiviral Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0166-3542(94)90034-5","volume":"23","author":"R Cali\u00f2","year":"1994","unstructured":"Cali\u00f2 R, Viliani N, Balestra E, Sesa F, Hol\u00fd A, Balzarini J, et al. Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates. Antiviral Res 1994;23:77?89.","journal-title":"Antiviral Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0166-3542(94)90098-1","volume":"25","author":"N Villani","year":"1994","unstructured":"Villani N, Cali\u00f2 R, Balestra E, Balzarini J, de Clercq E, Fabrizi E, et al. 9-(2-Phosphonomethoxyethyl)adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system. Antiviral Res 1994;25:81?9.","journal-title":"Antiviral Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/AAC.35.8.1596","volume":"35","author":"H Yang","year":"1991","unstructured":"Yang H, Datema R. Prolonged and potent therapeutic and prophylactic effects of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine against herpes simplex virus type 2 infections in mice. Antimicrob Agents Chemother 1991;35:1596?600.","journal-title":"Antimicrob Agents Chemother"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jmv.1890370112","volume":"37","author":"J Neyts","year":"1992","unstructured":"Neyts J, Balzarini J, Naesens L, de Clercq E. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice. J Med Virol 1992;37:61?71.","journal-title":"J Med Virol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0166-3542(91)90055-V","volume":"16","author":"K Soike","year":"1991","unstructured":"Soike K, Huang J-Y, Bohm R, Hitchcock M, Martin JC. Evaluation of infrequent dosing regimens with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (S-HPMPC) on simian varicella infection in monkeys. Antiviral Res 1991;16:17?28.","journal-title":"Antiviral Res"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ijc.2910460233","volume":"46","author":"J Balzarini","year":"1990","unstructured":"Balzarini J, Naesens L, de Clercq E. Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine in vivo increases when it is less frequently administered. Int J Cancer 1990;46:337?40.","journal-title":"Int J Cancer"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0166-3542(91)90058-Y","volume":"16","author":"L Naessens","year":"1991","unstructured":"Naessens L, Balzarini J, de Clercq E. Single dose administration of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEADAP) in the prophylaxis of retrovirus infection in vivo. Antiviral Res 1991;16:53?64.","journal-title":"Antiviral Res"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1135\/cccc19872801","volume":"2","author":"A Hol\u00fd","year":"1987","unstructured":"Hol\u00fd A, Rosenberg I. Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compounds. Collect Czech Chem Commun 1987;2:2801?9.","journal-title":"Collect Czech Chem Commun"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00449687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00449687\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00449687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T01:43:34Z","timestamp":1585964614000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00449687"}},"subtitle":["A pilot study"],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF00449687"],"URL":"https:\/\/doi.org\/10.1007\/bf00449687","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}